Heterologous priming-boosting immunization of cattle with Mycobacterium tuberculosis 85A induces antigen-specific T-cell responses.

ग्रंथसूची विवरण
मुख्य लेखकों:	Taracha, E, Bishop, R, Musoke, A, Hill, A, Gilbert, S
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2003

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin.
द्वारा: Vordermeier, H, और अन्य
प्रकाशित: (2004)

Progress in DNA-based heterologous prime-boost immunization strategies for malaria.
द्वारा: Moore, A, और अन्य
प्रकाशित: (2004)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
द्वारा: Draper, S, और अन्य
प्रकाशित: (2005)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy.
द्वारा: Tchilian, E, और अन्य
प्रकाशित: (2013)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy
द्वारा: Tchilian, E, और अन्य
प्रकाशित: (2013)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting
द्वारा: Dean, G, और अन्य
प्रकाशित: (2014)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting.
द्वारा: Dean, G, और अन्य
प्रकाशित: (2014)

Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas.
द्वारा: Rühl, J, और अन्य
प्रकाशित: (2019)

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.
द्वारा: McShane, H, और अन्य
प्रकाशित: (2004)

Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
द्वारा: Tchilian, E, और अन्य
प्रकाशित: (2009)

Prime-boost immunisation strategies for tuberculosis.
द्वारा: Mcshane, H, और अन्य
प्रकाशित: (2005)

Incorporation of trehalose analogues into Mycobacterium Tuberculosis: antigen 85 and probes of bacterial infection
द्वारा: Backus, K
प्रकाशित: (2011)

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.
द्वारा: Schneider, J, और अन्य
प्रकाशित: (1999)

Erratum: Immunogenicity and protective efficacy of prime-boost regimens with recombinant δureC hly+ Mycobacterium bovis BCG and modified Vaccinia virus Ankara expressing M. tuberculosis antigen 85A against murine tuberculosis
द्वारा: Tchilian, E, और अन्य
प्रकाशित: (2011)

Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M
द्वारा: Venkatraman, N, और अन्य
प्रकाशित: (2017)

DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.
द्वारा: Hill, A, और अन्य
प्रकाशित: (2000)

Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression
द्वारा: Ramirez-Valdez, RA, और अन्य
प्रकाशित: (2023)

Environmental effects on protection against Mycobacterium tuberculosis after immunization with Ad85A.
द्वारा: Beverley, P, और अन्य
प्रकाशित: (2013)

Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates.
द्वारा: Spencer, A, और अन्य
प्रकाशित: (2012)

Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.
द्वारा: Lalvani, A, और अन्य
प्रकाशित: (2001)

Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant Delta ureC hly(+) Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis, (vol 77, pg 630, 2009)
द्वारा: Tchilian, E, और अन्य
प्रकाशित: (2011)

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
द्वारा: Vuola, J, और अन्य
प्रकाशित: (2005)

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
द्वारा: Shaw, RH, और अन्य
प्रकाशित: (2021)

Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol.
द्वारा: Bouillet, L, और अन्य
प्रकाशित: (2011)

Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.
द्वारा: Mcshane, H, और अन्य
प्रकाशित: (2002)

HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosis.
द्वारा: Klein, MR, और अन्य
प्रकाशित: (2001)

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
द्वारा: McAuliffe, J, और अन्य
प्रकाशित: (2021)

Effect of adenovirus dose and prime-boost interval on the immune kinetics of the effector immune response
द्वारा: Sridhar, S, और अन्य
प्रकाशित: (2005)

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria.
द्वारा: Keating, S, और अन्य
प्रकाशित: (2005)

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.
द्वारा: Gilbert, S, और अन्य
प्रकाशित: (2006)

Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model.
द्वारा: Yoshida, K, और अन्य
प्रकाशित: (2018)

Developing a personalized heterologous prime boost vaccination strategy for tumor therapy
द्वारा: Ramirez-Valdez, RA
प्रकाशित: (2021)

Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs.
द्वारा: Williams, A, और अन्य
प्रकाशित: (2005)

Immunogenicity of recombinant mycobacterium smegmatis expressing antigen 85b epitopes as a potential tuberculosis vaccine candidate
द्वारा: Kadir , Nur Ayuni
प्रकाशित: (2017)

Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function.
द्वारा: Dintwe, O, और अन्य
प्रकाशित: (2013)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
द्वारा: Sander, C, और अन्य
प्रकाशित: (2009)

Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa.
द्वारा: Jepson, A, और अन्य
प्रकाशित: (2001)

Quantitative association tests of immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa.
द्वारा: Wiart, A, और अन्य
प्रकाशित: (2004)

Heterologous priming-boosting immunization of cattle with Mycobacterium tuberculosis 85A induces antigen-specific T-cell responses.

समान संसाधन

समान संसाधन